Prostatype Genomics publishes monthly newsletter and its net sales for the third quarter of 2023
Prostatype Genomics publishes a monthly newsletter with a company update by CEO Fredrik Persson and a long interview with CMO Gerald Andreoli about the clinical activities in the United States, including a large clinical validation study. At the same time, the company announces that its net sales for the third quarter of 2023 amounted to approx. 530 TSEK, compared to 109 TSEK for the same period last year.Prostatype Genomics will, starting in December 2023, publish monthly newsletters to provide more comprehensive information to shareholders, investors and other interested parties about the